TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE B-

NCT07240896: A Clinical Study on the Treatment of Wilson Disease With ATP7B mRNA/LNP (DSL101)

Sponsor: DSciLab Co., Ltd. · Phase: PHASE1 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 20 pts

Competing Trials Overlap

2 Active Trials

Excess Burn Exposure

$2,076,992

Rescue Site Savings

+$1,377,136

Unlock Full NCT07240896 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07240896 Rescue Dossier →